Vic-ELF heart failure trial Skip to primary navigation Skip to main content
0 item $0.00

Can we improve the outcome of patients at risk of heart failure?

The Vic-ELF (Victorian study of echocardiographic detection of left ventricular dysfunction) study is a randomised trial to explore the benefits of screening and treating selected patients at risk of developing heart failure. The screening is done using a new imaging technique (strain imaging) in which specialists at the Baker Heart and Diabetes Institute have expertise.

Who can participate?

Participants must be aged 65 years and older and have one of the following:

  • diabetes
  • high blood pressure
  • overweight or obese.

If you are interested in participating or would like further information, please contact:

Jasmine Prichard
T:
+61 3 8532 1511
E: Baker.VICELF@baker.edu.au


More information

Heart failure is a problem that is growing to epidemic proportions, especially among the elderly. At present, there is no effective strategy for identifying heart failure, so patients present late in the course of the disease where hospitalisation is inevitable and treatment responses are poor.

Screening of 'at risk' patients with a combination of clinical scores and echo imaging is able to identify patients who are likely to develop heart failure.

The question that were are looking to answer is whether surveillance with strain imaging to detect left ventricular dysfunction can improve the heart failure outcomes of at risk patients. We anticipate that the prompt initiation of therapy in patients that are recognised to be in the earliest phase of heart failure will result in improved functional capacity and may even arrest the progression to heart failure.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more